FDA Peptide Update: Category 2 Removals Explained FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Is BPC 157 Banned? Oral vs. Injectable Forms Explained Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that